You just read:

The Leukemia & Lymphoma Society Expands its Innovative Therapy Acceleration Program ® (TAP) with a Novel Immunotherapy for Lymphoma Patients

News provided by

The Leukemia & Lymphoma Society

Apr 05, 2017, 10:00 ET